BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35319075)

  • 1. The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma.
    Matsui Y; Matsuda A; Maejima A; Shinoda Y; Nakamura E; Komiyama M; Fujimoto H
    Int J Clin Oncol; 2022 Jun; 27(6):1093-1100. PubMed ID: 35319075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer.
    Fan Z; Luo G; Gong Y; Xu H; Qian Y; Deng S; Huang Q; Yang C; Cheng H; Jin K; Liu C; Yu X
    Ann Surg Oncol; 2020 Oct; 27(10):4017-4025. PubMed ID: 32144621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy.
    Yang N; Han X; Yu J; Shu W; Qiu F; Han J
    J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the modified Glasgow Prognostic Score aid in the management of patients undergoing surgery for a soft-tissue sarcoma? : an international multicentre study.
    Spence S; Doonan J; Farhan-Alanie OM; Chan CD; Tong D; Cho HS; Sahu MA; Traub F; Gupta S;
    Bone Joint J; 2022 Jan; 104-B(1):168-176. PubMed ID: 34969280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma.
    Liang Y; Xiao W; Guan YX; Wang W; Chen HY; Fang C; Zhang X; Zhou ZW
    Oncotarget; 2017 Nov; 8(58):98135-98147. PubMed ID: 29228679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study.
    Fiore M; Ljevar S; Pasquali S; Morelli D; Callegaro D; Sanfilippo R; Barisella M; Sangalli C; Miceli R; Gronchi A
    Clin Cancer Res; 2023 Feb; 29(3):614-620. PubMed ID: 36478176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
    Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
    J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-based Indices Predicting Mortality in COVID-19.
    Cakirca G; Cakirca TD; Bindal A; Olcen M
    J Coll Physicians Surg Pak; 2023 Jan; 33(1):112-114. PubMed ID: 36597247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
    Choi ES; Kim HS; Han I
    Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
    Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
    World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate inflammatory markers for predicting survival in retroperitoneal sarcoma.
    Netanyahu Y; Gerstenhaber F; Shamai S; Sher O; Merimsky O; Klausner JM; Lahat G; Nizri E
    J Surg Oncol; 2020 Dec; 122(8):1655-1661. PubMed ID: 32808301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Reactive Protein-to-Albumin Ratio (CAR) and C-Reactive Protein-to-Lymphocyte Ratio (CLR) are Valuable Inflammatory Biomarker Combination for the Accurate Prediction of Periprosthetic Joint Infection.
    Shi W; Jiang Y; Tian H; Wang Y; Zhang Y; Yu T; Li T
    Infect Drug Resist; 2023; 16():477-486. PubMed ID: 36721632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
    Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
    BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma.
    Zhang T; Liu W; Xu C
    Front Oncol; 2023; 13():1166802. PubMed ID: 37746281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma.
    Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
    J Surg Oncol; 2013 Dec; 108(7):481-5. PubMed ID: 24018883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection.
    Gu L; Wang M; Cui X; Mo J; Yuan L; Mao F; Zhang K; Ng DM; Chen P; Wang D
    BMC Surg; 2020 Oct; 20(1):219. PubMed ID: 33008382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
    BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis.
    Imai T; Kojima Y; Shimoi T; Aiba H; Okuma HS; Saito A; Kita S; Yamamoto K; Maejima A; Nishikawa T; Sudo K; Noguchi E; Yoshida A; Matsui Y; Iwata S; Kobayashi E; Kawai A; Udagawa R; Fujiwara Y; Yonemori K
    Anticancer Res; 2024 May; 44(5):2125-2132. PubMed ID: 38677749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.